Luliconil Cream contains luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial dermatophytic infections such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation allows for targeted application to affected skin areas, promoting rapid symptom relief and resolution of infection. Luliconil Cream is typically applied once daily to the cleansed and dried affected area for a duration of 1 to 2 weeks, depending on the severity and type of infection. It is well tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site, which are generally transient. Luliconil Cream is contraindicated in patients with known hypersensitivity to luliconazole or any components of the formulation. It is recommended to avoid contact with eyes and mucous membranes. Use during pregnancy and lactation should be under medical supervision. Proper adherence to the prescribed regimen is essential to prevent recurrence and resistance development.